Neurona Therapeutics’ NRTX-1001, an investigational allogeneic regenerative neural cell therapy intended to treat drug-resistant mesial temporal lobe epilepsy (MTLE), has been granted regenerative medicine advanced therapy (RMAT)...
Chinese scientists say an immunotherapy treatment widely used in the fight against cancer has shown potential for non-cancer diseases, and a single shot can provide long-term...